Related Experiment Videos
Mismatch negativity in hyperactive children: effects of methylphenidate
B G Winsberg1, D C Javitt, G S Silipo
1Brookdale Hospital Medical Center, Brooklyn, NY 11212.
Psychopharmacology Bulletin
|January 1, 1993
Summary
Methylphenidate (MP) treatment may normalize brain activity in hyperkinetic children. This study found that MP reduced hyperactive behaviors and showed trends toward normalizing electrophysiological responses like P3 and mismatch negativity (MMN).
Area of Science:
- Neuroscience
- Developmental Psychology
- Pharmacology
Background:
- Hyperkinetic disorder is characterized by inattention and hyperactivity.
- Methylphenidate (MP) is a common treatment for hyperkinetic disorder.
- Understanding the neurophysiological effects of MP is crucial for optimizing treatment.
Purpose of the Study:
- To investigate the electrophysiological correlates of methylphenidate (MP) treatment in children with hyperkinetic disorder.
- To examine event-related potentials (ERPs) associated with auditory processing in hyperkinetic children before and during MP therapy.
- To explore potential information-processing abnormalities in hyperkinetic children and their sensitivity to MP.
Main Methods:
- Pilot study involving a small sample of hyperkinetic children (n=6) and controls (n=5).
- Electrophysiological recordings using event-related potentials (ERPs) during an auditory "oddball" task.
- Assessment of mismatch negativity (MMN) and P3 components in response to auditory stimuli under ignore and attend conditions.
Main Results:
- Methylphenidate (MP) significantly reduced hyperkinetic behaviors.
- Hyperkinetic children exhibited decreased P3 waveform amplitude, with a trend toward normalization during MP treatment.
- Abnormalities in mismatch negativity (MMN) latency and/or amplitude were observed in hyperkinetic children, also showing a trend toward normalization with MP.
Conclusions:
- Preliminary data suggest information-processing abnormalities in hyperkinetic children.
- These abnormalities may be responsive to methylphenidate (MP) therapy.
- Electrophysiological measures may serve as objective indicators of treatment response in hyperkinetic disorder.